MYC and prostate cancer: Similarly, SOX18 can enhance cell migration and proliferation in both in vitro and in vivo models of prostate cancer by promoting the transcription of the pro-growth factors TCF1, c-Myc, and cyclin D1 (Yin et al., 2017).